Find More Contacts for Lumosa Therapeutics
Protected Content
Consultant
Non-Management Pro Services
1 email found
View contacts for Lumosa Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit

Lumosa Therapeutics, a public traded company in Taipei Exchange (6535.TWO), is dedicated to the development of innovative new drugs for the treatment of neurological and inflammatory diseases of unmet medical needs. The company is actively engaged in scientific in-licensing and new drug development under the “reSEARCH and DEVELOPMENT” model. This

model is executed by a highly capable and experienced cross-functional teams of translational research, CMC, preclinical, clinical development, project management, regulatory affairs, intellectual property and business development experts.

Lists Featuring This Company

Taiwan Companies
5,260 Number of Organizations • $16.7B Total Funding Amount • 1,320 Number of Investors
Asia-Pacific (APAC) Biotechnology Companies
6,425 Number of Organizations • $98.3B Total Funding Amount • 9,896 Number of Investors
Taipei Companies
3,123 Number of Organizations • $7.4B Total Funding Amount • 1,121 Number of Investors
Biotechnology Companies With More Than 50 Employees
8,335 Number of Organizations • $738.3B Total Funding Amount • 19,754 Number of Investors

Frequently Asked Questions

Where is Lumosa Therapeutics's headquarters? Lumosa Therapeutics is located in Taipei, T'ai-pei, Taiwan.Who are Lumosa Therapeutics's competitors? Alternatives and possible competitors to Lumosa Therapeutics may include Rekindle Therapeutics and Felicitex Therapeutics.